EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aggrecan deficiency does not increase susceptibility to estrogen-induced growth plate senescence

Ameya Bendre, Henrique Hadad iD, Lars Ottosson iD, Claes Ohlsson iD, Sara H Windahl iD, Ola Nilsson iD

Journal of the Endocrine Society · 01.08.2026 · 10 (9)

DOI: 10.1210/jendso/bvag163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 22.07.2026. Verfasst von Ameya Bendre und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology and Center for Molecular Medicine, Department of Women's and Children's Health, Karolinska Institutet, Stockholm …. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, IngaBritt och Arne Lundbergs forskningsstiftelse, Stockholm County Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In growing children, estrogen accelerates skeletal maturation, leading to advanced bone age, earlier growth cessation, and epiphyseal fusion. Children with heterozygous pathogenic variants in the aggrecan gene (ACAN) typically exhibit postnatal growth failure, advanced bone age, and premature growth cessation. To investigate whether accelerated skeletal maturation in aggrecan deficiency reflects increased sensitivity to estrogen-induced growth plate senescence, we used a mouse model carrying a heterozygous truncating variant in Acan (Acan+/−). Consistent with the human phenotype, these mice display postnatal growth failure and early growth cessation. Seven-week-old ovariectomized (OVX) wild-type and Acan+/− mice received weekly estradiol cypionate (0.15 µg/g) or vehicle treatment for 4 weeks. As expected, OVX reduced and estradiol increased uterine weights in both genotypes. In wild-type mice, estradiol treatment significantly reduced tibial growth and several structural markers of growth plate function. In Acan+/− mice, fewer parameters were significantly affected by estradiol treatment. Importantly, we found no evidence that aggrecan deficiency increases susceptibility to estrogen-induced growth plate senescence. These findings challenge the hypothesis that accelerated skeletal maturation in ACAN deficiency reflects heightened estrogen sensitivity and instead point to intrinsic abnormalities of growth plate cartilage as a driver of premature growth cessation.

Schlagwörter

Stichwörter der Autor:innen

aggrecanestrogengenetic growth disordersgrowth plategrowth plate senescencelongitudinal bone growth

Autor:innen und Institutionen

  • Division of Pediatric Endocrinology and Center for Molecular Medicine, Department of Women's and Children's Health, Karolinska Institutet, Stockholm SE-171 76, Sweden.
  • Department of Pediatric Endocrinology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm SE-171 76, Sweden.
  • Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg SE-413 45…
  • Unit of Clinical Pharmacology, Department of Pharmaceuticals, Sahlgrenska University Hospital, Gothenburg SE-413 45, Sweden.
  • Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Huddinge SE-141 52, Sweden.

ORCID-Profile: Henrique Hadad, Lars Ottosson, Claes Ohlsson, Sara H Windahl, Ola Nilsson

Förderung

  • Swedish Research Council
  • IngaBritt och Arne Lundbergs forskningsstiftelse
  • Stockholm County Council
  • Erik and Edith Fernström Foundation for Medical Research, Promobilia
  • Swedish Rare Diseases Foundation
  • Sällskapet Barnavård
  • Wera Ekström’s Foundation for Pediatric Research
  • Stiftelsen Frimurare Barnhuset i Stockholm

Zitieren

APA

Bendre, A., Hadad, H., Ottosson, L., Ohlsson, C., Windahl, S. H., & Nilsson, O. (2026). Aggrecan deficiency does not increase susceptibility to estrogen-induced growth plate senescence. Journal of the Endocrine Society, 10(9). https://doi.org/10.1210/jendso/bvag163

Vancouver

Bendre A, Hadad H, Ottosson L, Ohlsson C, Windahl SH, Nilsson O. Aggrecan deficiency does not increase susceptibility to estrogen-induced growth plate senescence. Journal of the Endocrine Society. 2026;10(9). doi:10.1210/jendso/bvag163

BibTeX
@article{Bendre2026,
  author = {Bendre, Ameya and Hadad, Henrique and Ottosson, Lars and Ohlsson, Claes and Windahl, Sara H and Nilsson, Ola},
  title = {Aggrecan deficiency does not increase susceptibility to estrogen-induced growth plate senescence},
  journal = {Journal of the Endocrine Society},
  year = {2026},
  volume = {10},
  number = {9},
  doi = {10.1210/jendso/bvag163}
}
Kostenlos starten →